245 related articles for article (PubMed ID: 28900170)
21. Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.
Karpowicz RJ; Haney CM; Mihaila TS; Sandler RM; Petersson EJ; Lee VM
J Biol Chem; 2017 Aug; 292(32):13482-13497. PubMed ID: 28611062
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.
Oliveras-Salvá M; Macchi F; Coessens V; Deleersnijder A; Gérard M; Van der Perren A; Van den Haute C; Baekelandt V
Neurobiol Aging; 2014 Nov; 35(11):2625-2636. PubMed ID: 25037286
[TBL] [Abstract][Full Text] [Related]
23. Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies.
Schmid AW; Fauvet B; Moniatte M; Lashuel HA
Mol Cell Proteomics; 2013 Dec; 12(12):3543-58. PubMed ID: 23966418
[TBL] [Abstract][Full Text] [Related]
24. Protein arginylation, a global biological regulator that targets actin cytoskeleton and the muscle.
Kashina A
Anat Rec (Hoboken); 2014 Sep; 297(9):1630-6. PubMed ID: 25125176
[TBL] [Abstract][Full Text] [Related]
25. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
[TBL] [Abstract][Full Text] [Related]
26. Effects of Glutamate Arginylation on α-Synuclein: Studying an Unusual Post-Translational Modification through Semisynthesis.
Pan B; Kamo N; Shimogawa M; Huang Y; Kashina A; Rhoades E; Petersson EJ
J Am Chem Soc; 2020 Dec; 142(52):21786-21798. PubMed ID: 33337869
[TBL] [Abstract][Full Text] [Related]
27. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
28. Liat1, an arginyltransferase-binding protein whose evolution among primates involved changes in the numbers of its 10-residue repeats.
Brower CS; Rosen CE; Jones RH; Wadas BC; Piatkov KI; Varshavsky A
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4936-45. PubMed ID: 25369936
[TBL] [Abstract][Full Text] [Related]
29. Bacterial Expression and Purification of Recombinant Arginyltransferase (ATE1) and Arg-tRNA Synthetase (RRS) for Arginylation Assays.
Wang J; Kashina AS
Methods Mol Biol; 2015; 1337():67-71. PubMed ID: 26285882
[TBL] [Abstract][Full Text] [Related]
30. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.
Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA
Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187
[TBL] [Abstract][Full Text] [Related]
31. Global analysis of posttranslational protein arginylation.
Wong CC; Xu T; Rai R; Bailey AO; Yates JR; Wolf YI; Zebroski H; Kashina A
PLoS Biol; 2007 Oct; 5(10):e258. PubMed ID: 17896865
[TBL] [Abstract][Full Text] [Related]
32. Interactions between calcium and alpha-synuclein in neurodegeneration.
Rcom-H'cheo-Gauthier A; Goodwin J; Pountney DL
Biomolecules; 2014 Aug; 4(3):795-811. PubMed ID: 25256602
[TBL] [Abstract][Full Text] [Related]
33. Arginyltransferase regulates alpha cardiac actin function, myofibril formation and contractility during heart development.
Rai R; Wong CC; Xu T; Leu NA; Dong DW; Guo C; McLaughlin KJ; Yates JR; Kashina A
Development; 2008 Dec; 135(23):3881-9. PubMed ID: 18948421
[TBL] [Abstract][Full Text] [Related]
34. Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study.
Yoshinaga S; Yamanaka T; Miyazaki H; Okuzumi A; Hiyama A; Murayama S; Nukina N
Biochem Biophys Res Commun; 2020 Feb; 522(3):655-661. PubMed ID: 31785806
[TBL] [Abstract][Full Text] [Related]
35. O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effect.
Wu K; Li D; Xiu P; Ji B; Diao J
Phys Biol; 2020 Dec; 18(1):016002. PubMed ID: 32906104
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Arginylated Peptides by Subtractive Edman Degradation.
Kashina AS; Yates JR
Methods Mol Biol; 2015; 1337():105-7. PubMed ID: 26285887
[TBL] [Abstract][Full Text] [Related]
37. Post-translational arginylation and intracellular proteolysis.
Bohley P; Kopitz J; Adam G; Rist B; von Appen F; Urban S
Biomed Biochim Acta; 1991; 50(4-6):343-6. PubMed ID: 1801699
[TBL] [Abstract][Full Text] [Related]
38. Posttranslational arginylation enzyme Ate1 affects DNA mutagenesis by regulating stress response.
Kumar A; Birnbaum MD; Patel DM; Morgan WM; Singh J; Barrientos A; Zhang F
Cell Death Dis; 2016 Sep; 7(9):e2378. PubMed ID: 27685622
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.
Paleologou KE; Oueslati A; Shakked G; Rospigliosi CC; Kim HY; Lamberto GR; Fernandez CO; Schmid A; Chegini F; Gai WP; Chiappe D; Moniatte M; Schneider BL; Aebischer P; Eliezer D; Zweckstetter M; Masliah E; Lashuel HA
J Neurosci; 2010 Mar; 30(9):3184-98. PubMed ID: 20203178
[TBL] [Abstract][Full Text] [Related]
40. Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein.
Sengupta U; Puangmalai N; Bhatt N; Garcia S; Zhao Y; Kayed R
Mol Neurobiol; 2020 Jun; 57(6):2741-2765. PubMed ID: 32350746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
